Menu
We invite you to a stimulating discussion on January 23, 2025, at 3:00 PM CET, organized as part of the COST Action CA21117. This online...
Our Action Chair, Cristoforo Comi, Professor of Neurology at the University of Eastern Piedmont in Italy, participated in the āInflammation Phenotyping Workshopā organized by the...
IMMUPARKNET COST Action recently concluded the first training school entitled “Models for Parkinsonās Disease: From Basics to Translation” held at the Faculty of Health Sciences,...
Short-term Scientific Missions (STSM) are institutional visits aimed at supporting individual mobility and fostering collaborations by allowing scientists to visit an institution and contribute to...
We’re thrilled to share the latest publication from our Working Group 2 (WG2) at IMMUPARKNET COST Action 21117! Entitled “Experimental Models to Study Immune Dysfunction...
š Exciting News from IMMUPARKNET COST Action 21117 Annual Meeting! š This year’s IMMUPARKNET COST Action Annual Conference took place in the beautiful city of...
š§ Neuroscience Academy Denmark Lecture on Parkinson’s Disease š§ š Date & Time: March 22, 2024, 1:00 pm (CET) š Location: Aarhus University, Building 1613,...
Date and Venue:June 6-8, 2024Faculty of Health Sciences, University of Beira Interior, CovilhĆ£, Portugal Contents: Theoretical lectures on Parkinson’s models (Drosophila, Zebrafish, rodents), brain modeling...
WG5 andĀ IMMUPARKNET CA21117 COST Action invites you to join our secondĀ webinarĀ session withĀ Dr. Guillaume DorothĆ©eā that will take place online onĀ January 18th 2024, 3:00 pm (CET)....
COST (European Cooperation in
Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
The Action focuses on Parkinsonās disease (PD) challenges and aims at establishing an innovative, multi-interdisciplinary Network, fostering the exchange of expertise among outstanding experts, from different countries and institutions, involving scientists studying immunity in PD but also immunity in other neurodegenerative diseases.
MoU – 031/22
CSO Approval date – 27/05/2022
Start date – 20/09/2022
End date – 19/09/2026
Design by Boutik
